Board Meetings

BSE Code Company Date Purpose
table-arrow 511523 Veerhealth Care 28-Mar-2026 Veerhealth Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/03/2026 inter alia to consider and approve The proposal for raising of funds by way of issue of one or more instruments including equity shares/ convertible securities either by way of Preferential Issue/ Rights Issue/ QIP/ or any other mode as may be considered subject to such approvals as may be required and to transact other businesses
table-arrow 517449 Magna Electrocas 28-Mar-2026 Magna Electro Castings Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/03/2026 ,inter alia, to consider and approve Annual operating plan and Capital expenditure budget for the financial year 2026-27.
table-arrow 518011 Keerthi Indus 28-Mar-2026 Keerthi Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/03/2026 inter alia to consider and approve 1. The Addendum to the Business Transfer Agreement (BTA) entered into by the company for the purpose of slump sale which was approved by the Board of Directors on 29th May 2025 and subsequently by the Shareholders on 10th July 2025. 2. Any other Business matter with the permission of the Chairperson.
table-arrow 526530 IIRM Holdings 28-Mar-2026 Inter alia, to consider and approve the following matters: 1. To consider and approve the provision of a Corporate Guarantee by the Company in favour of India Insure Risk Management and Insurance Broking Services Private Limited, its wholly owned subsidiary. 2. To consider and approve raising of potential funds from eligible investors. 3. To consider any other business as may be placed before the Board.
table-arrow 531035 Eraaya Lifespace 28-Mar-2026 Eraaya Lifespaces Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/03/2026 inter alia to consider and approve 1. to review the status of completion of the audit and publication of the Companys unaudited standalone and consolidated financial results for the quarters ended September 30 2025 and December 31 2025 and to note related developments and consider such actions as may be deemed appropriate 2. to consider and approve certain changes in the Companys leadership and governance framework including the appointment of Key Managerial Personnel (KMP) institution of select roles and realignment of Board Committees and functional structures as may be considered appropriate. 3. Any other matter with the permission of the Chair.